Aridis pharmaceuticals announces third quarter 2020 results

San jose, calif., nov. 20, 2020 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported financial and corporate results for the...

ARDS Ratings Summary

ARDS Quant Ranking